Yusheng Wu
Yusheng Wu US
Patent application number | Description | Published |
---|---|---|
20100292203 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 11-18-2010 |
Yusheng Wu, New Haven, CT US
Patent application number | Description | Published |
---|---|---|
20090118502 | BIARYL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME - The present invention relates generally to the field of anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of compounds having both a biaryl moiety and at least one heterocylic moiety that are useful as such agents. | 05-07-2009 |
20100022772 | PROCESS FOR THE SYNTHESIS OF BIARYL OXAZOLIDNONES - The present invention relates to processes for the preparation of biaryl oxazolidinones. These compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. | 01-28-2010 |
20100234591 | BIARYL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME - The present invention relates generally to the field of anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of compounds having both a biaryl moiety and at least one heterocylic moiety that are useful as such agents. | 09-16-2010 |
20100234615 | Process for the synthesis of triazoles - The present invention relates to processes for the preparation of triazoles. These compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. | 09-16-2010 |
20120010200 | Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same - The present invention relates generally to the field of anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of compounds having both a biaryl moiety and at least one heterocylic moiety that are useful as such agents. | 01-12-2012 |
20120220566 | Antimicrobial Compounds and Methods of Making and Using the Same - The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals. | 08-30-2012 |
20120252747 | MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME - The present invention provides macrocyclic compounds useful as therapeutic agents of the formula: | 10-04-2012 |
20130066076 | Process for the Synthesis of Biaryl Oxazolidinones - The present invention relates to processes for the preparation of biaryl oxazolidinones. These compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. | 03-14-2013 |
20140031402 | Process for the Syntheses of Triazoles - The present invention relates to processes for the preparation of triazoles. These compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. | 01-30-2014 |
20140073624 | Biaryl Heterocyclic Compounds and Methods of Making and Using the Same - The present invention relates generally to the field of anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of compounds having both a biaryl moiety and at least one heterocylic moiety that are useful as such agents. | 03-13-2014 |
20150072970 | BIARYL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME - The present invention relates generally to the field of anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of compounds having both a biaryl moiety and at least one heterocylic moiety that are useful as such agents. | 03-12-2015 |
Yusheng Wu, New York, NY US
Patent application number | Description | Published |
---|---|---|
20080200445 | Heterocyclic aspartyl protease inhibitors - Disclosed are compounds of the formula I | 08-21-2008 |
20090258868 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 10-15-2009 |
20090306047 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 12-10-2009 |
20090312341 | CYCLIC AMINE BACE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT - Disclosed are novel compounds of the formula | 12-17-2009 |
20100152138 | CYCLIC AMINE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT - Disclosed are compounds of the formula | 06-17-2010 |
20110218194 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 09-08-2011 |
20120231017 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 09-13-2012 |
20120231018 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 09-13-2012 |
20120232064 | ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of formula I | 09-13-2012 |
20120276118 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 11-01-2012 |
20130004518 | CYCLIC AMINE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT - Disclosed are compounds of the formula | 01-03-2013 |
20130018066 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 01-17-2013 |
20130296348 | Bis-Quinazoline Derivatives as Inhibitors for Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase - Novel bis-quinazoline derivatives as tyrosine kinase inhibitors, synthesis of these compounds, and novel methods for treating tyrosine kinase mediated diseases or disorders using these compounds are disclosed. In particular, the present invention provides tethered quinazoline derivative dimers as inhibitors to the epidermal growth factor receptor (EGFR) tyrosine kinase, pharmaceutical compositions thereof, and their therapeutic uses for treating EGFR kinase-mediated diseases or disorders, such as various cancers, as well as synthetic methods for preparing these novel compounds. | 11-07-2013 |
20140057910 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 02-27-2014 |
20140128361 | CYCLIC AMIDE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT - Disclosed are compounds of the formula | 05-08-2014 |
Yusheng Wu, Kenilworth, NJ US
Patent application number | Description | Published |
---|---|---|
20110110957 | PHENYL-SUBSTITUTED 2-IMINO-3-METHYL PYRROLO PYRIMIDINONE COMPOUNDS AS BACE-1 INHIBITORS, COMPOSITIONS, AND THEIR USE - In its many embodiments, the present invention provides certain 2-imino-3-methyl pyrrolo pyrimidone compounds, including compounds Formula (II): and include tautomers, steroisomers, or pharmaceutically acceptable salts or solvates of said compounds, stereoisomers, or said tautomers, wherein R | 05-12-2011 |
Yusheng Wu, Fujian CN
Patent application number | Description | Published |
---|---|---|
20150047657 | Tobacco Shred Feeding Treatment Device and Method for Improving Heat Energy and Feed Liquid Absorption Efficiency of Tobacco Shred - The invention relates to a tobacco shred feeding treatment device and a method for improving the heat energy and feed liquid absorption efficiency of tobacco shred, comprising: a tobacco shred feeding machine, said tobacco shred feeding machine mainly comprises a roller, a process warm-air pipe, a power blower, a heater, a steam nozzle, a feed liquid nozzle and an air inlet pipe; the process warm-air is blown into said roller from said air inlet pipe via said steam nozzle and said heater under the action of said power blower, and mixed with the tobacco shred; said air inlet pipe is provided directly under the central axis of said roller; the opening of said air inlet pipe faces up obliquely, and the opening direction of which could be adjusted into any position within the roller according to the requirements; said steam nozzle is mounted between the power blower and the heater, to achieve heating the condensed water in the steam, and to avoid directly injecting the steam to burn the tobacco shred. Under the premise that it is not necessary to configure the tunnel heating and humidifying equipment, the process warm-air with steam can contact with the tobacco shred sufficiently to improve the heat energy and feed liquid absorption efficiency and uniformity. | 02-19-2015 |